The Law Library

Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - Modification of Dispensing Restrictions for Buprenorphine (Us Department of Health and Human Services Regulation) (Hhs) (2018 Edition) The Law Library

Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - Modification of Dispensing Restrictions for Buprenorphine (US Department of Health and Human Services Regulation) (HHS) (2018 Edition) The Law Library presents the complete text of the Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - Modification of Dispensing Restrictions for Buprenorphine (US Department of Health and Human Services Regulation) (HHS) (2018 Edition). Updated as of May 29, 2018 This final rule amends the federal opioid treatment program regulations by modifying the dispensing requirements for buprenorphine and buprenorphine combination products approved by the Food and Drug Administration (FDA) for opioid dependence and used in federally certified and registered opioid treatment programs. In particular, this rule would allow opioid treatment programs more flexibility in dispensing take-home supplies of buprenorphine-removing restrictions on the time a patient needs to be in treatment in order to receive take-home supplies-after the assessment and documentation of a patient's responsibility and stability to receive opioid addiction treatment medication. Opioid treatment programs that use these products in the treatment of opioid dependence will continue to adhere to all other federal treatment standards established for methadone. This book contains: - The complete text of the Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - Modification of Dispensing Restrictions for Buprenorphine (US Department of Health and Human Services Regulation) (HHS) (2018 Edition) - A table of contents with the page number of each section